Obsessive–compulsive disorder (OCD) is a chronic and disabling psychiatric disease with a lifetime prevalence of 2–3%. People with OCD suffer from intrusive, unwanted and recurrent thoughts (obsessions) and/or repetitive ritualistic behaviors (compulsions). The aim of this study is to quantify the dimensions of ritualistic ‘compulsive-like’ behavior in quinpirole-induced behavior in rats by using T-pattern behavioral analysis. In addition, we investigated whether the behavioral effects elicited by quinpirole sensitization remained after 2 weeks of cessation of treatment. Finally, to study the neurobiological underpinnings of this ‘compulsive-like’ behavior, we investigated the effect of quinpirole treatment on the extracellular dopamine levels in the nucleus accumbens. Once established, ‘compulsive-like’ behavior is dependent upon quinpirole administration, as this behavior rapidly normalized after cessation of treatment. After a single dose of quinpirole the dopamine level decreased more in saline pre-treated animals as compared with animals given quinpirole treatment continuously. Furthermore, T-pattern analysis revealed that quinpirole-induced behavior consists, unlike OCD rituals, of a smaller behavioral repertoire. As seen in patients with OCD, quinpirole-treated animals performed these behaviors with a high rate of repetition. These findings suggest that quinpirole-induced behavior mimics only part of the compulsive behavior as shown in OCD patients.
AouizerateBCunyEBardinetEYelnikJMartin-GuehlCRotgeJY. (2009) Distinct striatal targets in treating obsessive-compulsive disorder and major depression. J Neurosurg111: 775–779.
2.
de OliveiraARReimerAEBrandãoML (2006) Dopamine D2 receptor mechanisms in the expression of conditioned fear. Pharmacol Biochem Behav84: 102–111.
3.
DenysDvan MegenHWestenbergH (2002) Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: An open label study. J Clin Psychiatry63: 8.
4.
DenysDKlompmakersAAWestenbergHGM (2004a) Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology176: 195–203.
5.
DenysDvan der WeeNJanssenJde GeusFWestenbergHGM (2004b) Low level of dopaminergic D2 receptor binding in obsessive–compulsive disorder. Biol Psychiatry55: 1041–1045.
6.
DenysD (2006) Pharmacotherapy of obsessive-compulsive disorder and obsessive–compulsive spectrum disorders. Psychiatr Clin N Am29: 553–584.
7.
DenysDMantioneM (2009) Deep brain stimulation in obsessive–compulsive disorder. Prog Brain Res175: 419–427.
8.
DvorkinAPerreaultMLSzechtmanH (2006) Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive–compulsive disorder. Behav Brain Research169: 303–311.
9.
EinatHSzechtmanH (1993) Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behav Brain Res54: 35–41.
10.
JoelDAvisarA (2001) Excessive lever pressing following post-training signal attenuation in rats: A possible animal model of obsessive–compulsive disorder?. Behav Brain Res123: 77–87.
11.
JoelD (2006) Current animal models of obsessive compulsive disorder: A critical review. Prog Neuropsychopharmacol Biol Psychiatry30: 374–388.
12.
KoeltzowTEAustinJDVezinaP (2003) Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology44: 102–110.
13.
KorffSHarveyBH (2006) Animal models of obsessive–compulsive disorder: Rationale to understanding psychobiology and pharmacology. Psychiatr Clin N Am29: 371–390.
14.
MagnussonMS (2000) Discovering hidden time patterns in behavior: T-patterns and their detection. Behav Res Methods Instrum Comput32: 93–110.
15.
MalletLPolosanMJaafariNBaupNWelterMLFontaineD. (2008) Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med13: 2121–2134.
16.
MundtAKleinJJoelDHeinzADjodari-IraniAHarnackD. (2009) High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci29: 2401–2412.
17.
PallantiSHollanderEBienstockCKoranLLeckmanJMarazzitiD. (2002) Treatment non-response in OCD: Methodological issues and operational definitions. Int J Neuropsychopharmacol5: 181–191.
18.
PaxinosGWatsonC (2005) The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
19.
PerreaultMLSeemanPSzechtmanH (2007) Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive compulsive disorder (OCD). Behav Neurosci121: 976–991.
20.
SantiagoMWesterinkBH (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schiedebergs Arch Pharmacol342: 407–414.
21.
SassonYZoharJChopraMLustigMIancuIHendlerT (1997) Epidemiology of obsessive–compulsive disorder: A world view. J Clin Psychiatry12: 7–10.
22.
SheehanDVLecrubierYSheehanKHAmorimPJanavsJWeillerE. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry20: 22–23.
23.
SturmVLenartzDKoulousakiATreuerHHerholzKKleinJC. (2003) The nucleus accumbens: A target for deep brain stimulation in obsessive–compulsive and anxiety disorders. J Chem Neuroanat26: 293–299.
24.
SullivanRMTalangbayanHEinatHSzechtmanH (1998) Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience83: 781–789.
25.
SzechtmanHEckertMJTseWSBoersmaJTBonuraCAMcClellandJZ. (2001) Compulsive checking behavior of quinpirole-sensitized rats as an animal model of obsessive–compulsive disorder (OCD): Form and control. BMC Neurosci2: 4.
26.
SzechtmanHSulisWEilamD (1998) Quinpirole induces compulsive checking behavior in rats: A potential animal model of obsessive–compulsive disorder (OCD). Behav Neurosci112: 1475–1485.
27.
van der WeeNJStevensHHardemanJAMandlRCDenysDAvan MegenHJ. (2004) Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]ß-CIT SPECT. Am J Psychiatry161: 2201–2206.
28.
VulinkNCCDenysDFluitmanSBAHAMeinardiJCMWestenbergHGM (2009) Quetiapine augments the effect of citalopram in non-refractory obsessive–compulsive disorder: A randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry70: 1001–1008.
29.
WelchJMLuJRodriguizRMTrottaNCPecaJDingJD. (2007) Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature448: 894–900.
30.
WestenbergHGMFinebergNADenysD (2007) Neurobiology of obsessive–compulsive disorder: Serotonin and beyond. CNS Spectr12: 14–27.
31.
WinterCMundtAJalaliRJoelDHarnackDMorgensternR. (2008) High-frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole-induced compulsive checking behavior in rats. Exp Neurol210: 217–228.
32.
ZadicarioPRonenSEilamD (2007) Modulation of quinpirole-induced compulsive–like behavior in rats by environmental changes: Implications for OCD rituals and for exploration and navigation. BMC Neurosci8: 23.
33.
ZorRHermeshHSzechtmanHEilamD (2009a) Turning order into chaos through repetition and addition of elementary acts in obsessive–compulsive disorder (OCD). World J Biol Psychiatry10: 480–487.
34.
ZorRKerenHHermeshHSzechtmanHMortJEilamD (2009b) Obsessive–compulsive disorder: A disorder of pessimal (non-functional) motor behaviour. Acta Psychiatr Scand120: 288–298.
